Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection ...

Patients with postural orthostatic tachycardia syndrome treated with ivabradine have better heart-rate control when standing. HealthDay News — Ivabradine lowers heart rate (HR) and relieves symptoms ...

On Wednesday, the U.S. Food and Drug Administration approved Amgen's Corlanor, a drug that helps reduce the risk of hospitalization for patients with systolic heart failure, which develops when the ...

Review the side-effects of Ivabradine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Sacubitril/valsartan and ivabradine are drugs that help in the treatment of severe heart failure through different mechanisms. They reduce the need for hospitalizations due to heart failure They have ...

Ivabradine is a novel agent that lowers heart rate by inhibiting the I(f) current in the sinoatrial node. The SHIFT trial evaluated the drug’s efficacy in 6,558 patients with symptomatic chronic heart ...

Here, we report the case of a 54-year-old man with an inoperable metastatic paraganglioma in whom systemic targeted radiotherapy with 177 Lu-Dotatate was indicated. He had hypertension and tachycardia ...